Kadri Altundag Selected Research

Neoplasm Metastasis (Metastasis)

1/2021	A positive conversion in Hormone Receptor and HER2 status and other metastatic sites might have a impact on survival for breast cancer patients with ovarian metastases.
1/2021	The impact of efficacy of receptor conversion on metastases directed therapies in liver metastases with breast cancer.
11/2019	All-oral (vinorelbin plus capecitabine) combination regimen might be preferable to oral vinoreline or weeky paclitaxel in estrogen receptor-positive, HER2-negative patients with visceral metastasis.
7/2019	CA-125 might be good predictive tumor biomarker for earlier detection of serosal metastases including the ovarian metastasis in high-risk invasive lobular breast cancer.
11/2018	Retesting HER2 status in axillary node metastases is important potential as a guide to subsequent therapy after pathologic complete eradication of cytologically proven hormone receptor positive and HER2-negative primary breast cancer following neoadjuvant treatment.
11/2018	A positive conversion in hormone receptor and HER2 status might have an impact on survival after liver resection for breast cancer metastases.
7/2018	Clinical Associations with ABO Blood Group and Rhesus Blood Group Status in Patients with Breast Cancer: A Nationwide Retrospective Study of 3,944 Breast Cancer Patients in Turkey.
7/2018	Receptor conversion in breast cancer patients with liver metastases after hepatectomy might affect survival.
1/2018	CA 15-3 elevation during post-metastasectomy period may occur in breast cancer patients with oligometastatic liver metastases.
12/2017	Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kadri Altundag Research Topics

Disease

234	Breast Neoplasms (Breast Cancer) 05/2024 - 12/2003
68	Neoplasms (Cancer) 01/2023 - 01/2004
42	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2004
22	Triple Negative Breast Neoplasms 04/2024 - 01/2008
10	Brain Neoplasms (Brain Tumor) 01/2021 - 02/2005
9	Multiple Myeloma 07/2021 - 01/2005
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2007 - 04/2004
8	Obesity 04/2017 - 01/2005
7	Osteonecrosis (Kienbock's Disease) 07/2021 - 06/2006
7	Cardiotoxicity 12/2017 - 12/2012
7	Osteoporosis 01/2016 - 12/2005
6	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2023 - 07/2005
6	Arthralgia (Joint Pain) 03/2020 - 12/2007
4	Calcinosis 01/2021 - 01/2006
4	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2005
4	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 11/2003
3	Pathologic Complete Response 03/2020 - 11/2017
3	Ductal Carcinoma 01/2019 - 05/2016
3	Lymphedema (Milroy Disease) 01/2018 - 01/2017
3	Overweight 04/2017 - 06/2013
3	Adenocarcinoma 01/2017 - 06/2005
3	Lymphoma (Lymphomas) 01/2015 - 04/2004
3	Nasopharyngeal Carcinoma 01/2012 - 01/2004
3	Lung Neoplasms (Lung Cancer) 01/2007 - 08/2004
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2007 - 01/2005
2	Lobular Carcinoma 05/2020 - 01/2019
2	Residual Neoplasm 09/2019 - 01/2007
2	Contracture 11/2018 - 11/2005
2	Alopecia (Baldness) 04/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

48	Hormones (Hormone)IBA 05/2024 - 01/2004
37	Trastuzumab (Herceptin)FDA Link 09/2021 - 01/2004
25	Aromatase InhibitorsIBA 07/2020 - 10/2004
20	Estrogen ReceptorsIBA 01/2022 - 01/2004
19	Tamoxifen FDA LinkGeneric 05/2024 - 12/2003
15	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 07/2004
14	Diphosphonates (Bisphosphonates)IBA 11/2017 - 01/2004
13	Capecitabine (Xeloda)FDA Link 05/2024 - 11/2011
13	taxaneIBA 01/2023 - 01/2005
12	Zoledronic Acid (Zometa)FDA Link 07/2021 - 01/2004
12	Progesterone Receptors (Progesterone Receptor)IBA 09/2020 - 01/2004
12	Phenobarbital (Luminal)FDA Link 09/2020 - 04/2009
12	Estrogens (Estrogen)FDA Link 07/2020 - 01/2004
12	ErbB Receptors (EGF Receptor)IBA 11/2019 - 06/2005
11	AnthracyclinesIBA 05/2021 - 01/2005
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 01/2005
9	Vitamin D FDA LinkGeneric 03/2019 - 01/2004
8	human ERBB2 proteinIBA 09/2021 - 01/2005
7	eribulin FDA Link 10/2023 - 09/2015
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2004
7	Fluorouracil (Carac)FDA LinkGeneric 07/2007 - 11/2003
6	Vinorelbine (Navelbine)FDA LinkGeneric 10/2022 - 04/2014
6	pertuzumabIBA 09/2021 - 10/2012
5	C-Reactive ProteinIBA 12/2023 - 02/2005
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2021 - 12/2011
5	Letrozole (Femara)FDA LinkGeneric 03/2020 - 12/2003
5	Lapatinib (GW572016)FDA Link 01/2017 - 05/2010
4	Ado-Trastuzumab EmtansineIBA 09/2021 - 04/2013
4	Taxoids (Taxanes)IBA 05/2021 - 12/2008
4	Docetaxel (Taxotere)FDA Link 05/2021 - 04/2014
4	Calcifying NanoparticlesIBA 01/2021 - 01/2005
4	Progesterone FDA LinkGeneric 07/2020 - 04/2008
4	Blood Group Antigens (Blood Groups)IBA 07/2018 - 06/2013
4	Biomarkers (Surrogate Marker)IBA 05/2017 - 04/2008
4	AndrogensIBA 01/2016 - 01/2005
4	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2004
4	Monoclonal AntibodiesIBA 08/2013 - 01/2004
4	Cisplatin (Platino)FDA LinkGeneric 01/2007 - 01/2004
3	olaparibIBA 11/2023 - 01/2015
3	Pentoxifylline (Trental)FDA LinkGeneric 01/2023 - 01/2006
3	Proton Pump InhibitorsIBA 01/2022 - 01/2017
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2018 - 01/2004
3	exemestane (Aromasin)FDA Link 01/2015 - 10/2004
3	Epirubicin (Ellence)FDA LinkGeneric 04/2014 - 01/2005
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014 - 01/2006
3	Cadherins (E-Cadherin)IBA 07/2012 - 01/2004
3	Pamidronate (Aredia)FDA LinkGeneric 06/2008 - 01/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2008 - 01/2005
3	Imatinib Mesylate (Gleevec)FDA Link 11/2005 - 01/2005
2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 02/2005
2	CardiotoxinsIBA 01/2023 - 03/2011
2	palbociclibIBA 01/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 03/2003
2	Tumor Biomarkers (Tumor Markers)IBA 07/2019 - 04/2008
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 12/2012
2	Androgen Receptors (Androgen Receptor)IBA 09/2018 - 09/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 09/2004
2	Selective Estrogen Receptor Modulators (SERM)IBA 08/2017 - 01/2006

Therapy/Procedure

52	Therapeutics 01/2022 - 01/2004
47	Drug Therapy (Chemotherapy) 04/2024 - 01/2004
23	Neoadjuvant Therapy 05/2021 - 02/2005
21	Radiotherapy 01/2023 - 01/2004
11	Adjuvant Chemotherapy 03/2021 - 12/2005
3	Mastectomy (Mammectomy) 01/2019 - 01/2017
3	Breast Implants (Breast Implant) 11/2018 - 11/2005
3	Duration of Therapy 01/2016 - 12/2014
3	Chemoradiotherapy 01/2015 - 01/2005
2	Adjuvant Radiotherapy 11/2018 - 09/2015
2	Sutures (Suture) 01/2018 - 01/2017
2	Mammaplasty (Breast Reconstruction) 01/2018 - 02/2006
2	Combination Drug Therapy (Combination Chemotherapy) 04/2017 - 01/2012